PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23598928-3 2013 Additional therapy with itraconazole leads to the decrease of total IgE to the limits recommended for proper omalizumab dosing (30-1500 kUA/l). Itraconazole 24-36 immunoglobulin heavy constant epsilon Homo sapiens 68-71 12743557-8 2003 Itraconazole reduced systemic immune activation, leading to a decrease in serum IgE levels (310 IU/mL) compared with levels seen in the placebo group (increase of 18 IU/mL, P <.01) and a decrease in IgG levels to A fumigatu s (15.4 IU/mL) compared with levels seen in the placebo group (increase of 3.7 IU/mL, P =.03). Itraconazole 0-12 immunoglobulin heavy constant epsilon Homo sapiens 80-83 26549342-4 2015 Prednisolone 0.5 mg/kg/day and Itraconazole improved his symptoms and IgE levels. Itraconazole 31-43 immunoglobulin heavy constant epsilon Homo sapiens 70-73 10027433-1 1999 STUDY OBJECTIVES: (1) To determine the relationship between IgE levels and the prevalence of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis (CF) patients, (2) to establish the usefulness of assessing atopy as an identifying risk factor for ABPA, (3) to evaluate the clinical course of patients receiving and not receiving itraconazole as reflected in oral steroid dose requirements and number of acute episodes of ABPA, and (4) to determine the role of acute episodes of ABPA in pulmonary exacerbations of CF. Itraconazole 341-353 immunoglobulin heavy constant epsilon Homo sapiens 60-63 23598928-4 2013 Itraconazole, used as bridge therapy, provided us the opportunity to start anti-IgE treatment in a patient with high levels of total IgE, beyond the upper limits recommended for proper prescription of omalizumab. Itraconazole 0-12 immunoglobulin heavy constant epsilon Homo sapiens 80-83 23598928-4 2013 Itraconazole, used as bridge therapy, provided us the opportunity to start anti-IgE treatment in a patient with high levels of total IgE, beyond the upper limits recommended for proper prescription of omalizumab. Itraconazole 0-12 immunoglobulin heavy constant epsilon Homo sapiens 133-136 21141064-6 2010 Following the administration of micafungin and itraconazole, the cavity lesion diminished in size, and his eosinophil and serum IgE levels decreased. Itraconazole 47-59 immunoglobulin heavy constant epsilon Homo sapiens 128-131